NIH-funded research P01 program project

Serotonin-containing brain cells that help breathing when opioids are used

Official title: Project 4: Serotonergic cell subtypes ameliorate sleep-disordered breathing in the setting of opioids

Funded at Beth Israel Deaconess Medical Center · NIH-11415650 · Data updated 2026-11-12

Aims to understand how certain brain serotonin cells can reduce opioid-related sleep breathing problems while keeping pain relief.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionBeth Israel Deaconess Medical Center
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 1, 2020
Project endAugust 31, 2030
Funding year2026
Award (this year)$375,152
NIH project number5P01HL149630-07
Project IDNIH-11415650 on NIH RePORTER

Who could benefit from this research

Could help

Not applicable to patient participation in this grant as described (preclinical mechanistic studies in animals).

Less likely to help

No direct patient participation or benefit is described in this grant.

What this research studies

This project looks at how specific serotonin-producing neurons in the brainstem can lessen or prevent breathing problems caused by opioids during sleep, without blocking pain relief. Scientists will study the Tac1-Pet1 neuron group to see how they influence airway tone and breathing and why they are less affected by opioids. The work will use animal models to test neuron activation and its effects on breathing patterns during opioid exposure. Early data suggest that activating these neurons could improve breathing without compromising analgesia. The study could lay the groundwork for new approaches to safer pain management for patients requiring opioids.

Why it matters

Potential benefit: If successful, this research could lead to strategies that reduce opioid-related sleep breathing problems while preserving pain relief.

How similar studies have gone: Preliminary data indicate that specific neuron subtypes may modulate respiration in the context of opioids, suggesting potential for positive translational impact.

Where this research is happening

  • Beth Israel Deaconess Medical Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Vanderhorst, Veronique — Beth Israel Deaconess Medical Center
  • Study coordinator: Vanderhorst, Veronique

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.